With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine SERVICES OFFERED Consulting Business Trials Biospecimens NEWS OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 PneumoniaOpGen Wins Chinese NMPA Approval for the Curetis Unyvero SystemEpigenomics AG Plans to Challenge National Coverage Determination (NCD) Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer ScreeningUnyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage (BAL) Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections GBC BLOG FDA Authorizes New Device to Help Diagnose Pediatric AutismMirimus, Inc. Announces Publication of Scientific Paper Highlighting Pooled Saliva-Based Testing as an Effective, Cost-Efficient Approach to COVID-19 Surveillance Testing for SchoolsRADx Tech Inks Additional Contracts for COVID-19 Tests and SuppliesFirst Over-the-Counter Covid-19 Test Gets FDA Clearance
